---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-205378"
form_type: "8-K"
ticker: "OSRH"
cik: "0001840425"
company_name: "OSR Holdings, Inc."
filed_at: "2024-08-22T23:59:59+00:00"
generated_at: "2026-05-31T08:07:10.531182+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Bellevue Life Sciences receives second Nasdaq delisting notice for insufficient public holders

## Summary
- Nasdaq notified company on Aug 20, 2024 that it failed to regain compliance with minimum 300 public holders requirement by Aug 13, 2024 deadline.
- Company previously received initial notice on Feb 15, 2024 and submitted a compliance plan; extension granted until Aug 13, 2024.
- Company intends to timely request a hearing before Nasdaq Hearings Panel, which will automatically stay suspension or delisting.
- Securities affected: units (BLACU), common stock (BLAC), warrants (BLACW), rights (BLACR).

## SEC filing metadata
- accession: 0001193125-24-205378
- form_type: 8-K
- ticker: OSRH
- cik: 0001840425
- company_name: OSR Holdings, Inc.
- filed_at: 2024-08-22T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840425/000119312524205378/0001193125-24-205378-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840425/000119312524205378/d227622d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-205378
- JSON: https://secwatch.observer/filing/0001193125-24-205378.json
- Plain text: https://secwatch.observer/filing/0001193125-24-205378.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.